Chemotherapy toxicities and geriatric syndromes in older patients with malignant gliomas
- 1 January 2021
- journal article
- research article
- Published by Elsevier in Journal of Geriatric Oncology
- Vol. 12 (1) , 134-138
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Assessing depression in a geriatric cancer populationPsycho-Oncology, 2016
- Temozolomide versus standard 6-week radiotherapy versus hypofractionated radiotherapy in patients older than 60 years with glioblastoma: the Nordic randomised, phase 3 trialThe Lancet Oncology, 2012
- Predicting Chemotherapy Toxicity in Older Adults With Cancer: A Prospective Multicenter StudyJournal of Clinical Oncology, 2011
- Patterns of care in elderly glioblastoma patientsAnnals of Neurology, 2008
- A Practical Approach to Geriatric Assessment in OncologyJournal of Clinical Oncology, 2007
- Pretreatment Quality of Life and Functional Status Assessment Significantly Predict Survival of Elderly Patients With Advanced Non—Small-Cell Lung Cancer Receiving Chemotherapy: A Prognostic Analysis of the Multicenter Italian Lung Cancer in the Elderly StudyJournal of Clinical Oncology, 2005
- Geriatric Evaluation and Management Units in the Care of the Frail Elderly Cancer PatientThe Journals of Gerontology, Series A: Biological Sciences and Medical Sciences, 2005
- Radiotherapy plus Concomitant and Adjuvant Temozolomide for GlioblastomaNew England Journal of Medicine, 2005
- Abbreviated Course of Radiation Therapy in Older Patients With Glioblastoma Multiforme: A Prospective Randomized Clinical TrialJournal of Clinical Oncology, 2004
- Practice parameter: Anticonvulsant prophylaxis in patients with newly diagnosed brain tumors [RETIRED]Neurology, 2000